This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Monday's Small-Cap Winners & Losers

Gateway (GTW) ranked among the small-cap sector's big winners Monday, catapulting more than 50% in furious trading on M&A news.

Acer, a personal computer vendor based in Taiwan, agreed to snap up the Irvine, Calif., PC maker for $1.90 a share, or around $710 million. The all-cash deal, which represents a 57% premium to Gateway's latest closing price, should close by December.

Gateway shares surged 61 cents to $1.82, but the Russell 2000 still persisted downward, sliding 0.9% at 791.45. The S&P SmallCap 600 was off 0.7%.

Meanwhile another tech stock, Superconductor Technologies (SCON - Get Report), rocketed 78% to $5.94 after announcing it's in talks to forge a joint venture with Hunchun BaoLi Communication, a China-based maker of push-to-talk handsets, by the end of 2007.

Superconductor, based in Santa Barbara, Calif., said the proposed joint venture "would focus primarily on the manufacturing and marketing of [its] SuperLink interference elimination solution for the Chinese market."

ID Systems (IDSY - Get Report) jumped after saying Wal-Mart (WMT) has ordered its Wireless Asset Net industrial vehicle-management system for 13 more Wal-Mart sites under an existing 2006 agreement, which originally involved eight facilities. Shares of the Hackensack, N.J., company were up $1.73, or 17%, to $11.89. Wal-Mart stock recently ticked up 8 cents at $43.82.

On the flip side, biopharma Neurochem (NRMX) lost 43% after its Alzheimer's disease treatment, Alzhemed (generically called tramiprosate), didn't achieve the primary endpoints in its North American late-phase study, per top-line results.

The Canada-based company also said "it is not possible to draw definitive conclusions" on the drug's effects "due to significant interference from high between-site variations that complicated the statistical analyses beyond expectations." Given this, the Food and Drug Administration "advised that neither the proposed adjusted models nor any further adjustments could be used for this trial to provide results in support of a claim of clinical efficacy." Neurochem shares were down $2.40 to $3.16.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
IDSY $5.78 -1.20%
SCON $1.09 -0.91%
AAPL $126.44 -0.13%
FB $87.28 0.43%
GOOG $523.40 0.30%

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs